Regardless of the molecular mechanism, we have shown that the cancer cell transformation can be inhibited by the application of a Fab fragment derived from the anti-CD9 antibody, which prevents the uptake of EVs [123,124] (Figure 1A). Here, CD9 is linked to cancer.